Fig. 1
From: Challenges and new technologies in adoptive cell therapy
Summary of current adoptive cell therapies in cancer treatment. Th, helper T cell; CTL, cytotoxic T lymphocyte; PBMC, peripheral blood mononuclear cell; iPSC, induced pluripotent stem cell; hESC, human embryonic stem cell; UCB, umbilical cord blood; hPSC, human pluripotent stem cell; BM, bone marrow; ADCC, antibody-dependent cell-mediated cytotoxicity; CRS, cytokine release syndrome; ICANS, immune effector cell-associated neurotoxicity syndrome; GvHD, graft versus host disease; MMP, matrix metalloproteinase; ECM, extracellular matrix; RV, retrovirus; LV, lentivirus; and AdV, adenovirus